{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T02:32:19Z","timestamp":1789525939672,"version":"build-2803163510"},"reference-count":84,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jcehepatology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical and Experimental Hepatology"],"published-print":{"date-parts":[[2022,5]]},"DOI":"10.1016\/j.jceh.2021.10.001","type":"journal-article","created":{"date-parts":[[2021,10,15]],"date-time":"2021-10-15T04:23:53Z","timestamp":1634271833000},"page":"993-1002","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"title":["Recognizing Dysfunctional Innate and Adaptive Immune Responses Contributing to Liver Damage in Patients With Cirrhosis"],"prefix":"10.1016","volume":"12","author":[{"given":"Ruchika","family":"Goel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chundamannil Eapen","family":"Eapen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jceh.2021.10.001_bib1","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1038\/s41590-020-00845-6","article-title":"Trained immunity, tolerance, priming and differentiation: distinct immunological processes","volume":"22","author":"Divangahi","year":"2021","journal-title":"Nat Immunol"},{"key":"10.1016\/j.jceh.2021.10.001_bib2","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.jhep.2020.03.027","article-title":"Innate immune cells in cirrhosis","volume":"73","author":"Bernsmeier","year":"2020","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jceh.2021.10.001_bib3","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1038\/sj.cdd.4402170","article-title":"NK cells at the interface between innate and adaptive immunity","volume":"15","author":"Moretta","year":"2008","journal-title":"Cell Death Differ"},{"key":"10.1016\/j.jceh.2021.10.001_bib4","first-page":"651","article-title":"Mononuclear phagocytic system: new classification of macrophages, monocytes and of their cell line","volume":"47","author":"van Furth","year":"1972","journal-title":"Bull World Health Organ"},{"key":"10.1016\/j.jceh.2021.10.001_bib5","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1172\/JCI34431","article-title":"A\u00a0calculated response: control of inflammation by the innate immune system","volume":"118","author":"Barton","year":"2008","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.jceh.2021.10.001_bib6","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.semcdb.2015.05.004","article-title":"Human mononuclear phagocyte system reunited","volume":"41","author":"Haniffa","year":"2015","journal-title":"Semin Cell Dev Biol"},{"key":"10.1016\/j.jceh.2021.10.001_bib7","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1002\/hep.22034","article-title":"An organ with predominant innate immunity","volume":"47","author":"Gao","year":"2008","journal-title":"Hepatology"},{"key":"10.1016\/j.jceh.2021.10.001_bib8","doi-asserted-by":"crossref","first-page":"191","DOI":"10.4110\/in.2015.15.4.191","article-title":"Immune-mediated liver injury in hepatitis B virus infection","volume":"15","author":"Oh","year":"2015","journal-title":"Immune Netw"},{"key":"10.1016\/j.jceh.2021.10.001_bib9","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1016\/j.jhep.2005.02.009","article-title":"Immune-mediated liver injury","volume":"42","author":"Herkel","year":"2005","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jceh.2021.10.001_bib10","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1093\/toxsci\/kfq009","article-title":"Mechanisms of immune-mediated liver injury","volume":"115","author":"Adams","year":"2010","journal-title":"Toxicol Sci"},{"key":"10.1016\/j.jceh.2021.10.001_bib11","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1038\/nri3261","article-title":"Lighting the fires within: the cell biology of autoinflammatory diseases","volume":"12","author":"Park","year":"2012","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.jceh.2021.10.001_bib12","doi-asserted-by":"crossref","first-page":"725","DOI":"10.3390\/ijms17050725","article-title":"The relationship between NALP3 and autoinflammatory syndromes","volume":"17","author":"Campbell","year":"2016","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jceh.2021.10.001_bib13","doi-asserted-by":"crossref","first-page":"e297","DOI":"10.1371\/journal.pmed.0030297","article-title":"A\u00a0proposed classification of the immunological diseases","volume":"3","author":"McGonagle","year":"2006","journal-title":"PLoS Med"},{"issue":"2 suppl 1","key":"10.1016\/j.jceh.2021.10.001_bib14","doi-asserted-by":"crossref","first-page":"S54","DOI":"10.1002\/hep.21060","article-title":"The liver as an immunological organ","volume":"43","author":"Racanelli","year":"2006","journal-title":"Hepatol Baltim Md"},{"key":"10.1016\/j.jceh.2021.10.001_bib15","first-page":"321","article-title":"The current immune function of hepatic dendritic cells","volume":"4","author":"Hsu","year":"2007","journal-title":"Cell Mol Immunol"},{"key":"10.1016\/j.jceh.2021.10.001_bib16","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1189\/jlb.70.2.163","article-title":"Functional heterogeneity in liver and lung macrophages","volume":"70","author":"Laskin","year":"2001","journal-title":"J\u00a0Leukoc Biol"},{"key":"10.1016\/j.jceh.2021.10.001_bib17","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/j.jhep.2014.10.006","article-title":"The immunophenotype of antigen presenting cells of the mononuclear phagocyte system in normal human liver--a systematic review","volume":"62","author":"Strauss","year":"2015","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jceh.2021.10.001_bib18","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1038\/s41575-018-0020-y","article-title":"Liver sinusoidal endothelial cells - gatekeepers of hepatic immunity","volume":"15","author":"Shetty","year":"2018","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.jceh.2021.10.001_bib19","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1034\/j.1600-065X.2000.917309.x","article-title":"Innate immune recognition: mechanisms and pathways","volume":"173","author":"Medzhitov","year":"2000","journal-title":"Immunol Rev"},{"key":"10.1016\/j.jceh.2021.10.001_bib20","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1038\/s41575-020-0334-4","article-title":"Understanding, predicting and achieving liver transplant tolerance: from bench to bedside","volume":"17","author":"Thomson","year":"2020","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.jceh.2021.10.001_bib21","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1038\/cmi.2016.3","article-title":"Liver immunology and its role in inflammation and homeostasis","volume":"13","author":"Robinson","year":"2016","journal-title":"Cell Mol Immunol"},{"key":"10.1016\/j.jceh.2021.10.001_bib22","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.jaut.2015.08.020","article-title":"Immunity, tolerance and autoimmunity in the liver: a comprehensive review","volume":"66","author":"Doherty","year":"2016","journal-title":"J\u00a0Autoimmun"},{"key":"10.1016\/j.jceh.2021.10.001_bib23","doi-asserted-by":"crossref","first-page":"3755","DOI":"10.4049\/jimmunol.1600818","article-title":"The acute-on-chronic liver failure syndrome, or when the innate immune system goes astray","volume":"197","author":"Cl\u00e0ria","year":"2016","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.jceh.2021.10.001_bib24","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1002\/hep.1840120611","article-title":"The human hepatic asialoglycoprotein receptor is a target antigen for liver-infiltrating T cells in autoimmune chronic active hepatitis and primary biliary cirrhosis","volume":"12","author":"L\u00f6hr","year":"1990","journal-title":"Hepatology"},{"key":"10.1016\/j.jceh.2021.10.001_bib25","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/S0953-6205(02)00089-4","article-title":"Autoantibodies and defined target autoantigens in autoimmune hepatitis: an overview","volume":"13","author":"Dalekos","year":"2002","journal-title":"Eur J Intern Med"},{"key":"10.1016\/j.jceh.2021.10.001_bib26","doi-asserted-by":"crossref","first-page":"1756","DOI":"10.1111\/j.1440-1746.2006.04748.x","article-title":"Autoimmune hepatitis","volume":"21","author":"Eapen","year":"2006","journal-title":"J\u00a0Gastroenterol Hepatol"},{"key":"10.1016\/j.jceh.2021.10.001_bib27","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.jceh.2013.12.002","article-title":"HLA DRB1 alleles discriminate the manifestation of autoimmune hepatitis as type 1 or type 2 in north Indian population","volume":"4","author":"Kaur","year":"2014","journal-title":"J\u00a0Clin Exp Hepatol"},{"key":"10.1016\/j.jceh.2021.10.001_bib28","first-page":"967","article-title":"HLA genotyping in type-I autoimmune hepatitis in Western India","volume":"51","author":"Amarapurkar","year":"2003","journal-title":"J\u00a0Assoc Phys India"},{"key":"10.1016\/j.jceh.2021.10.001_bib29","doi-asserted-by":"crossref","first-page":"3874","DOI":"10.3892\/mmr.2016.4998","article-title":"Altered function of monocytes\/macrophages in patients with autoimmune hepatitis","volume":"13","author":"Lin","year":"2016","journal-title":"Mol Med Rep"},{"key":"10.1016\/j.jceh.2021.10.001_bib30","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1038\/clpt.2011.58","article-title":"Case definition and phenotype standardization in drug-induced liver injury","volume":"89","author":"Aithal","year":"2011","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.jceh.2021.10.001_bib31","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1111\/apt.16153","article-title":"Anti-glycoprotein 2 (anti-GP2) IgA and anti-neutrophil cytoplasmic antibodies to serine proteinase 3 (PR3-ANCA): antibodies to predict severe disease, poor survival and cholangiocarcinoma in primary sclerosing cholangitis","volume":"53","author":"Wunsch","year":"2021","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.jceh.2021.10.001_bib32","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1136\/gut.24.1.38","article-title":"Association of primary sclerosing cholangitis with HLA-B8","volume":"24","author":"Chapman","year":"1983","journal-title":"Gut"},{"key":"10.1016\/j.jceh.2021.10.001_bib33","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1002\/JLB.5MR0320-200R","article-title":"Immune system and cholangiocytes: a puzzling affair in primary biliary cholangitis","volume":"108","author":"Ronca","year":"2020","journal-title":"J\u00a0Leukoc Biol"},{"key":"10.1016\/j.jceh.2021.10.001_bib34","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1080\/14397595.2019.1705537","article-title":"IgG4-related disease: how to place it in the spectrum of immune-mediated and rheumatologic disorders?","volume":"30","author":"Borges","year":"2020","journal-title":"Mod Rheumatol"},{"key":"10.1016\/j.jceh.2021.10.001_bib35","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.clim.2018.11.004","article-title":"New insights into immune cells cross-talk during IgG4-related disease","volume":"198","author":"Touzani","year":"2019","journal-title":"Clin Immunol"},{"key":"10.1016\/j.jceh.2021.10.001_bib36","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1080\/14397595.2018.1536364","article-title":"Cytokines produced by innate immune cells in IgG4-related disease","volume":"29","author":"Yoshikawa","year":"2019","journal-title":"Mod Rheumatol"},{"key":"10.1016\/j.jceh.2021.10.001_bib37","doi-asserted-by":"crossref","first-page":"2308","DOI":"10.3748\/wjg.v25.i19.2308","article-title":"Autoimmune hepatitis and IgG4-related disease","volume":"25","author":"Minaga","year":"2019","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.jceh.2021.10.001_bib38","doi-asserted-by":"crossref","first-page":"3126","DOI":"10.3748\/wjg.v26.i23.3126","article-title":"Review of primary sclerosing cholangitis with increased IgG4 levels","volume":"26","author":"Manganis","year":"2020","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.jceh.2021.10.001_bib39","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1007\/s12664-016-0708-2","article-title":"Plasma von Willebrand factor levels predict in-hospital survival in patients with acute-on-chronic liver failure","volume":"35","author":"Prasanna","year":"2016","journal-title":"Indian J Gastroenterol"},{"key":"10.1016\/j.jceh.2021.10.001_bib40","doi-asserted-by":"crossref","DOI":"10.1002\/hep.31838","article-title":"The addition of C-reactive protein and von Willebrand factor to MELD-Na improves prediction of waitlist mortality","author":"Starlinger","year":"2021","journal-title":"Hepatology"},{"key":"10.1016\/j.jceh.2021.10.001_bib41","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1002\/hep.31047","article-title":"The von Willebrand factor facilitates Model for end-stage liver disease-independent risk stratification on the waiting list for liver transplantation","volume":"72","author":"Gy\u00f6ri","year":"2020","journal-title":"Hepatology"},{"key":"10.1016\/j.jceh.2021.10.001_bib42","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/j.jhep.2015.11.021","article-title":"Macrophage activation markers predict mortality in patients with liver cirrhosis without or with acute-on-chronic liver failure (ACLF)","volume":"64","author":"Gr\u00f8nb\u00e6k","year":"2016","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jceh.2021.10.001_bib43","article-title":"Targetting raised von Willebrand factor levels in liver diseases: opening up newer therapeutic avenues","author":"Goel","year":"2020","journal-title":"EMJ Hepatol"},{"key":"10.1016\/j.jceh.2021.10.001_bib44","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1002\/pbc.21039","article-title":"HLH-2004: diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis","volume":"48","author":"Henter","year":"2007","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.jceh.2021.10.001_bib45","doi-asserted-by":"crossref","first-page":"2465","DOI":"10.1182\/blood.2018894618","article-title":"Recommendations for the management of hemophagocytic lymphohistiocytosis in adults","volume":"133","author":"La Ros\u00e9e","year":"2019","journal-title":"Blood"},{"key":"10.1016\/j.jceh.2021.10.001_bib46","first-page":"96","article-title":"Hemophagocytic lymphohistiocytosis secondary to acute hepatitis E infection: a rare association","volume":"66","author":"Ranjan","year":"2018","journal-title":"J\u00a0Assoc Phys India"},{"key":"10.1016\/j.jceh.2021.10.001_bib47","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1007\/s12098-015-2021-y","article-title":"Hemophagocytic lymphohistiocytosis associated with hepatitis A and hepatitis E Co-infection","volume":"83","author":"Choudhary","year":"2016","journal-title":"Indian J Pediatr"},{"key":"10.1016\/j.jceh.2021.10.001_bib48","doi-asserted-by":"crossref","first-page":"103","DOI":"10.2169\/internalmedicine.53.1013","article-title":"Autoimmune-associated hemophagocytic syndrome originating from autoimmune hepatitis with a successful response to therapy","volume":"53","author":"Saito","year":"2014","journal-title":"Intern Med"},{"key":"10.1016\/j.jceh.2021.10.001_bib49","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1007\/s12328-016-0638-7","article-title":"Drug-induced liver injury with autoimmune features complicated with hemophagocytic syndrome","volume":"9","author":"Hayashi","year":"2016","journal-title":"Clin J Gastroenterol"},{"key":"10.1016\/j.jceh.2021.10.001_bib50","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.3390\/cells9051175","article-title":"Macrophage activation markers, CD163 and CD206, in acute-on-chronic liver failure","volume":"9","author":"Nielsen","year":"2020","journal-title":"Cells"},{"key":"10.1016\/j.jceh.2021.10.001_bib51","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1136\/annrheumdis-2015-208982","volume":"75","author":"Ravelli","year":"2016","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jceh.2021.10.001_bib52","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1586\/1744666X.2015.1058159","article-title":"Clinical features and correct diagnosis of macrophage activation syndrome","volume":"11","author":"Cron","year":"2015","journal-title":"Expert Rev Clin Immunol"},{"key":"10.1016\/j.jceh.2021.10.001_bib53","doi-asserted-by":"crossref","first-page":"1786","DOI":"10.1016\/j.cgh.2018.04.045","article-title":"Neutrophil-to-Lymphocyte ratio associates independently with mortality in hospitalized patients with cirrhosis","volume":"16","author":"Rice","year":"2018","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jceh.2021.10.001_bib54","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1007\/s12664-020-01134-8","article-title":"Serum C-reactive protein and neutrophil-to-lymphocyte ratio as predictors of survival in cirrhotic patients with systemic inflammatory response syndrome and bacterial infection","volume":"40","author":"Tapadia","year":"2021","journal-title":"Indian J Gastroenterol"},{"key":"10.1016\/j.jceh.2021.10.001_bib55","doi-asserted-by":"crossref","first-page":"619039","DOI":"10.3389\/fimmu.2020.619039","article-title":"Characterization of blood immune cells in patients with decompensated cirrhosis including ACLF","volume":"11","author":"Weiss","year":"2020","journal-title":"Front Immunol"},{"key":"10.1016\/j.jceh.2021.10.001_bib56","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.jhep.2018.02.022","article-title":"The prognostic value of acute-on-chronic liver failure during the course of severe alcoholic hepatitis","volume":"69","author":"Serst\u00e9","year":"2018","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jceh.2021.10.001_bib57","doi-asserted-by":"crossref","DOI":"10.1097\/MEG.0000000000002056","article-title":"Reticuloendothelial activation correlates with disease severity and predicts mortality in severe alcoholic hepatitis","author":"Vijayalekshmi","year":"2021","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.jceh.2021.10.001_bib58","doi-asserted-by":"crossref","first-page":"158","DOI":"10.4103\/cmi.cmi_68_20","article-title":"Von-Willebrand factor: a biomarker to predict in-hospital survival in patients with severe and very severe alcoholic hepatitis","volume":"18","author":"Tiwari","year":"2020","journal-title":"Curr Med Issues"},{"key":"10.1016\/j.jceh.2021.10.001_bib59","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1097\/MEG.0000000000001491","article-title":"Systematic review: role of elevated plasma von-Willebrand factor as predictor of mortality in patients with chronic liver disease","volume":"31","author":"Eidelberg","year":"2019","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.jceh.2021.10.001_bib60","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.jceh.2020.08.007","article-title":"Determinants of outcomes in autoimmune hepatitis presenting as acute on chronic liver failure without extrahepatic organ dysfunction upon treatment with steroids","volume":"11","author":"Sharma","year":"2021","journal-title":"J\u00a0Clin Exp Hepatol"},{"key":"10.1016\/j.jceh.2021.10.001_bib61","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1002\/hep.30205","article-title":"Flare of autoimmune hepatitis causing acute on chronic liver failure: diagnosis and response to corticosteroid therapy","volume":"70","author":"Anand","year":"2019","journal-title":"Hepatology"},{"key":"10.1016\/j.jceh.2021.10.001_bib62","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.jhep.2018.12.008","article-title":"Acute-on-chronic liver failure in patients with alcohol-related liver disease","volume":"70","author":"Gustot","year":"2019","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jceh.2021.10.001_bib63","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1111\/liv.14806","article-title":"Therapeutic plasma-exchange improves systemic inflammation and survival in acute-on-chronic liver failure: a propensity-score matched study from AARC","volume":"41","author":"Maiwall","year":"2021","journal-title":"Liver Int"},{"key":"10.1016\/j.jceh.2021.10.001_bib64","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.jhep.2015.08.018","article-title":"High-volume plasma exchange in patients with acute liver failure: an open randomised controlled trial","volume":"64","author":"Larsen","year":"2016","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jceh.2021.10.001_bib65","article-title":"Standard-volume plasma exchange improves outcomes in patients with acute liver failure: a randomized controlled trial","author":"Maiwall","year":"2021","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jceh.2021.10.001_bib66","doi-asserted-by":"crossref","first-page":"47","DOI":"10.4103\/ghep.ghep_18_20","article-title":"Low-volume plasma exchange and low-dose steroid to treat severe liver injury","volume":"1","author":"Zachariah","year":"2021","journal-title":"Gastroenterol Hepatol Endosc Pract"},{"key":"10.1016\/j.jceh.2021.10.001_bib67","doi-asserted-by":"crossref","first-page":"219","DOI":"10.3748\/wjg.v26.i2.219","article-title":"Plasma exchange in patients with acute and acute-on-chronic liver failure: a systematic review","volume":"26","author":"Tan","year":"2020","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.jceh.2021.10.001_bib68","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1007\/s12072-020-10053-x","article-title":"Plasma perfusion combined with plasma exchange in chronic hepatitis B-related acute-on-chronic liver failure patients","volume":"14","author":"Yang","year":"2020","journal-title":"Hepatol Int"},{"key":"10.1016\/j.jceh.2021.10.001_bib69","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/S1499-3872(16)60084-X","article-title":"Plasma exchange-centered artificial liver support system in hepatitis B virus-related acute-on-chronic liver failure: a nationwide prospective multicenter study in China","volume":"15","author":"Chen","year":"2016","journal-title":"Hepatobiliary Pancreat Dis Int"},{"key":"10.1016\/j.jceh.2021.10.001_bib70","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1007\/s12072-016-9703-z","article-title":"Plasma exchange for acute on chronic liver failure: is there a light at the end of the tunnel?","volume":"10","author":"Maiwall","year":"2016","journal-title":"Hepatol Int"},{"key":"10.1016\/j.jceh.2021.10.001_bib71","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/j.jceh.2021.07.010","article-title":"Low volume plasma exchange and low dose steroid improve survival in patients with alcohol related acute on chronic liver failure and severe alcoholic hepatitis \u2013 preliminary experience","volume":"12","author":"Kumar","year":"2021","journal-title":"J\u00a0Clin Exp Hepatol"},{"key":"10.1016\/j.jceh.2021.10.001_bib72","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1111\/j.1477-2574.2009.00086.x","article-title":"Aetiology and outcome of acute liver failure","volume":"11","author":"Marudanayagam","year":"2009","journal-title":"HPB (Oxford)"},{"issue":"suppl 3","key":"10.1016\/j.jceh.2021.10.001_bib73","first-page":"S268","article-title":"Etiopathogenesis of acute hepatic failure: eastern versus Western countries","volume":"17","author":"Acharya","year":"2002","journal-title":"J\u00a0Gastroenterol Hepatol"},{"key":"10.1016\/j.jceh.2021.10.001_bib74","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1007\/s12664-021-01178-4","article-title":"Rodenticide ingestion is an important cause of acute hepatotoxicity in Tamil Nadu, southern India","volume":"40","author":"Govindarajan","year":"2021","journal-title":"Indian J Gastroenterol"},{"key":"10.1016\/j.jceh.2021.10.001_bib75","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1007\/s12664-019-00989-w","article-title":"Rodenticidal hepatotoxicity: raised plasma Von Willebrand factor levels predict in-hospital survival and preliminary report of the outcome of Von Willebrand factor reducing management protocol","volume":"38","author":"Sardar","year":"2019","journal-title":"Indian J Gastroenterol"},{"key":"10.1016\/j.jceh.2021.10.001_bib76","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/j.jceh.2020.12.006","article-title":"Effect of COVID-19 on pre-existing liver disease: what hepatologist should know ?","volume":"11","author":"Sharma","year":"2021","journal-title":"J\u00a0Clin Exp Hepatol"},{"key":"10.1016\/j.jceh.2021.10.001_bib77","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1016\/S0140-6736(20)30937-5","article-title":"Endothelial cell infection and endotheliitis in COVID-19","volume":"395","author":"Varga","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.jceh.2021.10.001_bib78","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1056\/NEJMoa2015432","article-title":"Pulmonary vascular endothelialitis, thrombosis, and angiogenesis in covid-19","volume":"383","author":"Ackermann","year":"2020","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jceh.2021.10.001_bib79","first-page":"1","article-title":"Plasma von Willebrand factor levels predict survival in COVID-19 patients across the entire spectrum of disease severity","author":"Thomas","year":"2021","journal-title":"Indian J Hematol Blood Transfus"},{"key":"10.1016\/j.jceh.2021.10.001_bib80","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.thromres.2020.05.001","article-title":"Targeting raised von Willebrand factor levels and macrophage activation in severe COVID-19: consider low volume plasma exchange and low dose steroid","volume":"192","author":"Zachariah","year":"2020","journal-title":"Thromb Res"},{"key":"10.1016\/j.jceh.2021.10.001_bib81","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1136\/gutjnl-2020-322118","article-title":"Comparison of mortality risk in patients with cirrhosis and COVID-19 compared with patients with cirrhosis alone and COVID-19 alone: multicentre matched cohort","volume":"70","author":"Bajaj","year":"2021","journal-title":"Gut"},{"key":"10.1016\/j.jceh.2021.10.001_bib82","first-page":"260A","article-title":"Autoimmune hepatitis triggered by COVID-19","author":"Hong","year":"2020","journal-title":"Hepatology"},{"key":"10.1016\/j.jceh.2021.10.001_bib83","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.jhep.2021.04.003","article-title":"Autoimmune hepatitis developing after coronavirus disease 2019 (COVID-19) vaccine: causality or casualty?","volume":"75","author":"Bril","year":"2021","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jceh.2021.10.001_bib84","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.1002\/hep.31797","article-title":"Outcome of COVID-19 in patients with autoimmune hepatitis: an international multicenter study","volume":"73","author":"Efe","year":"2021","journal-title":"Hepatology"}],"container-title":["Journal of Clinical and Experimental Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0973688321002590?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0973688321002590?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T06:10:11Z","timestamp":1760854211000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0973688321002590"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5]]},"references-count":84,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022,5]]}},"alternative-id":["S0973688321002590"],"URL":"https:\/\/doi.org\/10.1016\/j.jceh.2021.10.001","relation":{},"ISSN":["0973-6883"],"issn-type":[{"value":"0973-6883","type":"print"}],"subject":[],"published":{"date-parts":[[2022,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Recognizing Dysfunctional Innate and Adaptive Immune Responses Contributing to Liver Damage in Patients With Cirrhosis","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical and Experimental Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jceh.2021.10.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Indian National Association for Study of the Liver. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}